T. Rowe Price Associates
MR

T. Rowe Price Associates’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

T. Rowe Price Associates’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,142,841
Closed -$37M – 2564
2014
Q1 		$37M Sell
1,142,841
-1,791,944
-61% -$62.7M 0.01% 950
2013
Q4 		$107M Buy
+2,934,785
New +$114M 0.02% 605

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

T. Rowe Price Associates's MR Position: Q2 2014 in Review

T. Rowe Price Associates sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q2 2014, closing a stake of 1,142,841 shares — an estimated $37M sold.

T. Rowe Price Associates first reported a position in MR in Q4 2013 and held it in 2 quarters. The position peaked at $107M in Q4 2013. 131 funds tracked by Wall St. Rank hold MR as of Q2 2014.

  • T. Rowe Price Associates reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q2 2014 after selling out during the quarter.
  • T. Rowe Price Associates sold 1,142,841 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q2 2014, an estimated $37M.
  • T. Rowe Price Associates first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2013 and held it in 2 quarters.
  • T. Rowe Price Associates's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $107M in Q4 2013.
  • 131 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q2 2014.

Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.